Division 1.1Services and fees — ultrasound services
Start here
Get a plain-English read of Division 1.1
Turn the raw legal text into a practical explanation grounded in Health Insurance (Section 3C Diagnostic Imaging Services – Cardiac Services) Determination 2020.
Division 1.1 – Services and fees – ultrasound services
1.1.1 Application of ultrasound items
(1) For the purpose of subclause 1.1.1(2), if one or more services in paragraph (a) is rendered with one or more services in paragraph (b) for the same patient on the same day by the same medical practitioner, the fees that are set out in the items, other than the item with the highest fee, are reduced by 40%.
(2) The items applicable to the multiple services fee reduction rule are:
(a) a service to which one or more of items 55126, 55127, 55128, 55129, 55132, 55133, 55134 or 55137 apply; and
(b) a service to which one or more of items 55141, 55143, 55145 or 55146 apply.
(3) For any particular patient, item 55141, 55143, 55145 or 55146 applies if one or more of the following is applicable:
(a) if the patient displays one or more of the following symptoms of typical or atypical angina:
(i) constricting discomfort in the:
a. front of the chest; or
b. neck; or
c. shoulders; or
d. jaw; or
e. arms; or
(ii) the patient’s symptoms, as described in subparagraph (3)(a)(i), are precipitated by physical exertion; or
(iii) the patient’s symptoms, as described in subparagraph (3)(a)(i), are relieved by rest or glyceryl trinitrate within 5 minutes or less; or
(b) if the patient has known coronary artery disease and displays one or more symptoms that are suggestive of ischaemia:
(i) which are not adequately controlled with medical therapy; or
(ii) have evolved since the last functional study; or
(c) if the patient qualifies for one or more of the following indications:
(i) assessment of myocardial ischaemia with exercise is required if a patient with congenital heart lesions has undergone surgery and reversal of ischemia is considered possible; or
(ii) assessment indicates that resting 12 lead electrocardiogram changes are consistent with coronary artery disease or ischaemia, in a patient that is without known coronary artery disease; or
(iii) coronary artery disease related lesions, of uncertain functional significance, which have previously been identified on computed tomography coronary angiography or invasive coronary angiography; or
(iv) an assessment by a specialist or consultant physician indicates that the patient has potential non‑coronary artery disease, where a stress echocardiography study is likely to assist the diagnosis; or
(v) assessment indicates that the patient has undue exertional dyspnoea of uncertain aetiology; or
(vi) a pre‑operative assessment of a patient with functional capacity of less than 4 metabolic equivalents confirming that surgery is intermediate to high risk, and the patient has at least one of following conditions:
a. ischaemic heart disease or previous myocardial infarction; or
b. heart failure; or
c. stroke or transient ischaemic attack; or
d. renal dysfunction (serum creatinine greater than 170umol/L or 2 mg/dL or a creatinine clearance of less than 60 mL/min); or
e. diabetes mellitus requiring insulin therapy; or
(vii) assessment before cardiac surgery or catheter‑based interventions is required to:
a. increase the cardiac output to assess the severity of aortic stenosis; or
b. determine whether valve regurgitation worsens with exercise and/or correlates with functional capacity; or
c. correlate functional capacity with the ischaemic threshold; or
(viii) for patients where silent myocardial ischaemia is suspected, or due to the patient’s cognitive capacity or expressive language impairment, it is not possible to accurately assess symptom frequency based on medical history.
(4) For any particular patient, the request for a service to be provided under item 55141, 55143, 55145 or 55146 must identify the symptom/s or clinical indication/s, as outlined in subclause 1.1.1(3).
(5) For any particular patient, item 55141, 55143, 55145 or 55146 applies to a service if:
(a) the diagnostic imaging procedure is performed on premises equipped with resuscitation equipment, which includes a defibrillator; and
(b) the diagnostic imaging procedure is performed by a person trained in exercise testing and cardiopulmonary resuscitation who is in personal attendance during the procedure; and
(c) a second person trained in exercise testing and cardiopulmonary resuscitation is located at the diagnostic imaging premise where the procedure is performed and is immediately available to respond at the time the exercise test is performed on the patient, if required; and
(d) one of the persons mentioned in paragraphs (b) and (c) must be a medical practitioner.
(6) For any particular patient, item 55143 applies to a service if:
(a) the service is for an exercise stress echocardiography and includes all of the following:
(i) two‑dimensional recordings before exercise (baseline) from at least 2 acoustic windows; and
(ii) matching recordings at or immediately after peak exercise, which include at least parasternal short and long axis views, and apical 4‑chamber and 2 chamber views; and
(iii) recordings on digital media with equipment permitting display of baseline and matching peak images on the same screen; and
(iv) resting electrocardiogram and continuous multi‑channel electrocardiogram monitoring and recording during stress; and
(v) blood pressure monitoring and the recording of other parameters (including heart rate); or
(b) the service is for a pharmacological stress echocardiography and includes all of the following:
(i) two‑dimensional recordings before drug infusion (baseline) from at least 2 acoustic windows; and
(ii) matching recordings at least twice during drug infusion, including a recording at the peak drug dose, which include at least parasternal short and long axis views, and apical 4‑chamber and 2 chamber views; and
(iii) recordings on digital media with equipment permitting display of baseline and matching peak images on the same screen; and
(iv) resting electrocardiogram and continuous multi‑channel electrocardiogram monitoring and recording during stress; and
(v) blood pressure monitoring and the recording of other parameters (including heart rate).
(7) For any particular patient, a service associated with an attendance item listed in Part 2 of the general medical services table does not apply if a service to which item 55126, 55127, 55128, 55129, 55132, 55133, 55134, 55137, 55141, 55143, 55145 or 55146 applies is provided on the same day; unless:
(a) the attendance service is provided after the service where clinical management decisions are made; or
(b) the decision to perform the service on the same day was made during the attendance service subject to clinical assessment.
1.1.2 Limitation of ultrasound items 55141, 55143, 55145 and 55146
(1) For any particular patient, a service under item 55141, 55143, 55145 and 55146 does not apply if:
(a) the patient has body habitus or other physical condition/s (including heart rhythm disturbance) to the extent where a stress echocardiography would not provide adequate information; or
(b) the patient is unable to exercise to the extent where a stress echocardiography would not provide adequate information; or
(c) results of a previous imaging service indicate that a stress echocardiography service would not provide adequate information.
<table cellspacing="0" cellpadding="0" style="width:101.2%; border-collapse:collapse"><thead><tr><td colspan="3" style="border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-weight:bold">Group I1 - Ultrasound</span></p></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-weight:bold">Subgroup 7 – Transthoracic Echocardiogram and Stress Echocardiogram</span></p></td></tr><tr><td style="width:14.06%; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-weight:bold">Column 1</span></p><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-weight:bold">Item</span></p></td><td style="width:70.78%; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-weight:bold">Column 2</span></p><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-weight:bold">Description</span></p></td><td style="width:15.16%; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; text-align:right; page-break-after:avoid; line-height:12pt"><span style="font-weight:bold">Column 3</span></p><p style="margin-top:3pt; text-align:right; page-break-after:avoid; line-height:12pt"><span style="font-weight:bold">Fee ($)</span></p></td></tr></thead><tbody><tr><td style="width:14.06%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="line-height:normal"><a id="CU_5453681"></a><a id="CU_9455510"></a><a id="CU_18457523"></a><a id="CU_10459325"></a><span>55126</span></p></td><td style="width:70.78%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>Initial real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media:</span></p><ol class="awlist1" style="margin:0pt; padding-left:0pt"><li style="margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.79pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>for the investigation of any of the following:</span></li></ol><ol class="awlist2" style="margin:0pt; padding-left:0pt"><li style="margin-left:45.5pt; text-indent:-28.35pt; line-height:normal"><span style="width:17.97pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>symptoms or signs of cardiac failure; or</span></li><li style="margin-left:45.5pt; text-indent:-28.35pt; line-height:normal"><span style="width:14.91pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>suspected or known ventricular hypertrophy or dysfunction; or</span></li><li style="margin-left:45.5pt; text-indent:-28.35pt; line-height:normal"><span style="width:11.86pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>pulmonary hypertension; or</span></li><li style="margin-left:45.5pt; text-indent:-28.35pt; line-height:normal"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>valvular, aortic, pericardial, thrombotic or embolic disease; or</span></li><li style="margin-left:45.5pt; text-indent:-28.35pt; line-height:normal"><span style="width:15.52pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>heart tumour; or</span></li><li style="margin-left:45.5pt; text-indent:-28.35pt; line-height:normal"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>symptoms or signs of congenital heart disease; or</span></li><li style="margin-left:45.5pt; text-indent:-28.35pt; line-height:normal"><span style="width:9.41pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>other rare indications; and</span></li></ol><ol class="awlist3" style="margin:0pt; padding-left:0pt"><li style="margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.17pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>if the service involves all of the following, where possible:</span><ol class="awlist4" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-left:27.5pt; text-indent:-28.35pt"><span style="width:17.97pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and</span></li><li style="margin-top:3pt; margin-left:27.5pt; text-indent:-28.35pt"><span style="width:14.91pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of right ventricular structure and function with quantitative assessment; and</span></li><li style="margin-top:3pt; margin-left:27.5pt; text-indent:-28.35pt"><span style="width:11.86pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of left and right atrial structure including quantification of atrial sizes; and</span></li><li style="margin-top:3pt; margin-left:27.5pt; text-indent:-28.35pt"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of vascular connections of the heart including the great vessels and systemic venous structures; and</span></li><li style="margin-top:3pt; margin-left:27.5pt; text-indent:-28.35pt"><span style="width:15.52pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and</span></li><li style="margin-top:3pt; margin-left:27.5pt; text-indent:-28.35pt"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave doppler techniques with quantification of stenosis or regurgitation; and</span></li><li style="margin-top:3pt; margin-left:27.5pt; text-indent:-28.35pt"><span style="width:9.41pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of additional haemodynamic parameters including the assessment of pulmonary pressures; and</span></li></ol></li><li style="margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.79pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130), or an item in Subgroup 3 applies; and</span></li><li style="margin-left:17.15pt; text-indent:-17.15pt; line-height:normal"><span style="width:4.32pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>cannot be claimed within 24 months if a service associated with a service to which item 55127, 55128, 55129, 55132, 55133 or 55134 is provided</span></li></ol><p style="margin-top:3pt; line-height:normal"><span>For any particular patient, applicable not more than once in 24 months (R)</span></p></td><td style="width:15.16%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="text-align:right; line-height:normal"><span>234.15</span></p></td></tr><tr><td style="width:14.06%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="line-height:normal"><span>55127</span></p></td><td style="width:70.78%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>Repeat serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, for the investigation of known valvular dysfunction, if:</span></p><ol class="awlist5" style="margin:0pt; padding-left:0pt"><li style="margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.79pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the service involves all of the following, where possible:</span><ol class="awlist6" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:34.45pt; text-indent:-28.35pt"><span style="width:17.97pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and</span></li><li style="margin-top:3pt; margin-left:34.45pt; text-indent:-28.35pt"><span style="width:14.91pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of right ventricular structure and function with quantitative assessment; and</span></li><li style="margin-top:3pt; margin-left:34.55pt; text-indent:-28.35pt"><span style="width:11.86pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of left and right atrial structure including quantification of atrial sizes; and</span></li><li style="margin-top:3pt; margin-left:34.45pt; text-indent:-28.35pt"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of vascular connections of the heart including the great vessels and systemic venous structures; and</span></li><li style="margin-top:3pt; margin-left:34.45pt; text-indent:-28.35pt"><span style="width:15.52pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and</span></li><li style="margin-top:3pt; margin-left:34.45pt; text-indent:-28.35pt"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave doppler techniques with quantification of stenosis or regurgitation; and</span></li><li style="margin-top:3pt; margin-left:34.45pt; text-indent:-28.35pt"><span style="width:9.41pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of additional haemodynamic parameters including the assessment of pulmonary pressures; and</span></li></ol></li><li style="margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.17pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the service is requested by a specialist or consultant physician; and</span></li><li style="margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.79pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130), or an item in Subgroup 3 applies (R)</span></li></ol></td><td style="width:15.16%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="text-align:right; line-height:normal"><span>234.15</span></p></td></tr><tr><td style="width:14.06%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="line-height:normal"><span>55128</span></p></td><td style="width:70.78%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>Repeat serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, for the investigation of known valvular dysfunction, if:</span></p><ol class="awlist7" style="margin:0pt; padding-left:0pt"><li style="margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.79pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the service involves all of the following, where possible:</span><ol class="awlist8" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:37pt; text-indent:-28.35pt"><span style="width:17.97pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and</span></li><li style="margin-top:3pt; margin-left:37pt; text-indent:-28.35pt"><span style="width:14.91pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of right ventricular structure and function with quantitative assessment; and</span></li><li style="margin-top:3pt; margin-left:37pt; text-indent:-28.35pt"><span style="width:11.86pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of left and right atrial structure including quantification of atrial sizes; and</span></li><li style="margin-top:3pt; margin-left:37pt; text-indent:-28.35pt"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of vascular connections of the heart including the great vessels and systemic venous structures; and</span></li><li style="margin-top:3pt; margin-left:37pt; text-indent:-28.35pt"><span style="width:15.52pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and</span></li><li style="margin-top:3pt; margin-left:37pt; text-indent:-28.35pt"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave doppler techniques with quantification of stenosis or regurgitation; and</span></li><li style="margin-top:3pt; margin-left:37pt; text-indent:-28.35pt"><span style="width:9.41pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of additional haemodynamic parameters including the assessment of pulmonary pressures; and</span></li></ol></li><li style="margin-left:17.85pt; text-indent:-17.85pt; line-height:normal"><span style="width:5.02pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the service is requested by a medical practitioner (other than a specialist or consultant physician) at, or from, a practice location in:</span><ol class="awlist9" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:40.9pt; text-indent:-28.35pt"><span style="width:17.97pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>a Modified Monash 3 area; or</span></li><li style="margin-top:3pt; margin-left:40.9pt; text-indent:-28.35pt"><span style="width:14.91pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>a Modified Monash 4 area; or</span></li><li style="margin-top:3pt; margin-left:40.9pt; text-indent:-28.35pt"><span style="width:11.86pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>a Modified Monash 5 area; or</span></li><li style="margin-top:3pt; margin-left:40.9pt; text-indent:-28.35pt"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>a Modified Monash 6 area; or</span></li><li style="margin-top:3pt; margin-left:40.9pt; text-indent:-28.35pt"><span style="width:15.52pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>a Modified Monash 7 area; and</span></li></ol></li><li style="margin-left:17.85pt; margin-bottom:6pt; text-indent:-17.85pt; line-height:normal"><span style="width:5.64pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130) or an item in Subgroup 3 applies (R)</span></li></ol></td><td style="width:15.16%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="text-align:right; line-height:normal"><span>234.15</span></p></td></tr><tr><td style="width:14.06%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="line-height:normal"><span>55129</span></p></td><td style="width:70.78%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>Repeat serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, excluding valvular dysfunction (when valvular dysfunction is the primary condition):</span></p><ol class="awlist10" style="margin:0pt; padding-left:0pt"><li style="margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.79pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>for the investigation of any of the following:</span></li></ol><ol class="awlist11" style="margin:0pt; padding-left:0pt"><li style="margin-left:45.5pt; text-indent:-28.35pt; line-height:normal"><span style="width:17.97pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>symptoms or signs of cardiac failure; or</span></li><li style="margin-left:45.5pt; text-indent:-28.35pt; line-height:normal"><span style="width:14.91pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>suspected or known ventricular hypertrophy or dysfunction; or</span></li><li style="margin-left:45.5pt; text-indent:-28.35pt; line-height:normal"><span style="width:11.86pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>pulmonary hypertension; or</span></li><li style="margin-left:45.5pt; text-indent:-28.35pt; line-height:normal"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>aortic, thrombotic, embolic disease or pericardial disease (excluding isolated pericardial effusion or pericarditis); or</span></li><li style="margin-left:45.5pt; text-indent:-28.35pt; line-height:normal"><span style="width:15.52pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>heart tumour; or</span></li><li style="margin-left:45.5pt; text-indent:-28.35pt; line-height:normal"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>structural heart disease; or</span></li><li style="margin-left:45.5pt; text-indent:-28.35pt; line-height:normal"><span style="width:9.41pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>other rare indications; and</span></li></ol><ol class="awlist12" style="margin:0pt; padding-left:0pt"><li style="margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.17pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>if the service involves all of the following, where possible:</span><ol class="awlist13" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:40.7pt; text-indent:-28.35pt"><span style="width:17.97pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and</span><span></span></li><li style="margin-top:3pt; margin-left:40.7pt; text-indent:-28.35pt"><span style="width:14.91pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of right ventricular structure and function with quantitative assessment; and</span></li><li style="margin-top:3pt; margin-left:40.7pt; text-indent:-28.35pt"><span style="width:11.86pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of left and right atrial structure including quantification of atrial sizes; and</span></li><li style="margin-top:3pt; margin-left:40.7pt; text-indent:-28.35pt"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of vascular connections of the heart including the great vessels and systemic venous structures; and</span></li><li style="margin-top:3pt; margin-left:40.7pt; text-indent:-28.35pt"><span style="width:15.52pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and</span></li><li style="margin-top:3pt; margin-left:40.7pt; text-indent:-28.35pt"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave doppler techniques with quantification of stenosis or regurgitation if present; and</span></li><li style="margin-top:3pt; margin-left:40.65pt; text-indent:-28.35pt"><span style="width:9.41pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of additional haemodynamic parameters including the assessment of pulmonary pressures when possible; and</span></li></ol></li><li style="margin-left:17.85pt; text-indent:-17.85pt; line-height:normal"><span style="width:5.64pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the service is requested by a specialist or consultant physician; and</span></li><li style="margin-left:17.85pt; text-indent:-17.85pt; line-height:normal"><span style="width:5.02pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130) or an item in Subgroup 3 applies (R)</span></li></ol></td><td style="width:15.16%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="text-align:right; line-height:normal"><span>234.15</span></p></td></tr><tr><td style="width:14.06%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="line-height:normal"><span>55132</span></p></td><td style="width:70.78%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>Serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 4 acoustic windows, with recordings on digital media, for the investigation of a patient who is under 17 years of age, or a patient of any age with complex congenital heart disease, if:</span></p><ol class="awlist14" style="margin:0pt; padding-left:0pt"><li style="margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.79pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the service involves all of the following, where possible:</span><ol class="awlist15" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:40.65pt; text-indent:-28.35pt"><span style="width:17.97pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of ventricular structure and function including quantification of systolic function (if the ventricular configuration allows accurate quantification) using at least one of M-mode, 2-dimensional or 3-dimensional imaging; and</span></li><li style="margin-top:3pt; margin-left:40.65pt; text-indent:-28.35pt"><span style="width:14.91pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of diastolic function; and</span></li><li style="margin-top:3pt; margin-left:40.65pt; text-indent:-28.35pt"><span style="width:11.86pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of atrial structure including quantification of atrial sizes; and</span></li><li style="margin-top:3pt; margin-left:40.65pt; text-indent:-28.35pt"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of vascular connections of the heart including the great vessels and systemic venous structures; and</span></li><li style="margin-top:3pt; margin-left:40.65pt; text-indent:-28.35pt"><span style="width:15.52pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and</span></li><li style="margin-top:3pt; margin-left:40.65pt; text-indent:-28.35pt"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using relevant Doppler techniques with quantification; and</span></li><li style="margin-top:3pt; margin-left:40.65pt; text-indent:-28.35pt"><span style="width:9.41pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>subxiphoid views where recommended for congenital heart lesions; and</span></li><li style="margin-top:3pt; margin-left:40.65pt; text-indent:-28.35pt"><span style="width:6.36pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>additional haemodynamic parameters relevant to the clinical condition under review; and</span></li></ol></li><li style="margin-left:17.85pt; text-indent:-17.85pt; line-height:normal"><span style="width:5.02pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the service is performed by a specialist or consultant physician practising in the speciality of cardiology; and</span></li><li style="margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.79pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130) or an item in Subgroup 3 applies (R)</span></li></ol></td><td style="width:15.16%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="text-align:right; line-height:normal"><span>234.15</span></p></td></tr><tr><td style="width:14.06%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>55133</span></p></td><td style="width:70.78%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>Frequent repetition serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media:</span></p><ol class="awlist16" style="margin:0pt; padding-left:0pt"><li style="margin-left:16.1pt; text-indent:-16.1pt; line-height:normal"><span style="width:3.89pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>for the investigation of a patient:</span><ol class="awlist17" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:29.25pt; text-indent:-28.35pt"><span style="width:17.97pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>with isolated pericardial effusion or pericarditis; or</span></li><li style="margin-top:3pt; margin-left:29.25pt; text-indent:-28.35pt"><span style="width:14.91pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>who has commenced medication for non-cardiac purposes that have cardiotoxic side effects, and if the patient has a normal baseline study which requires echocardiograms to comply with the requirements of the Pharmaceutical Benefits Scheme; and</span></li></ol></li><li style="margin-left:16.15pt; text-indent:-16.15pt; line-height:normal"><span style="width:3.32pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the service involves all of the following, where possible:</span><ol class="awlist18" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:29.2pt; text-indent:-28.35pt"><span style="width:17.97pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and</span></li><li style="margin-top:3pt; margin-left:29.2pt; text-indent:-28.35pt"><span style="width:14.91pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of right ventricular structure and function with quantitative assessment; and</span></li><li style="margin-top:3pt; margin-left:29.2pt; text-indent:-28.35pt"><span style="width:11.86pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of left and right atrial structure including quantification of atrial sizes; and</span></li><li style="margin-top:3pt; margin-left:29.2pt; text-indent:-28.35pt"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of vascular connections of the heart including the great vessels and systemic venous structures; and</span></li><li style="margin-top:3pt; margin-left:29.2pt; text-indent:-28.35pt"><span style="width:15.52pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and</span></li><li style="margin-top:3pt; margin-left:29.2pt; text-indent:-28.35pt"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave doppler techniques with quantification of stenosis or regurgitation; and</span></li><li style="margin-top:3pt; margin-left:29.2pt; text-indent:-28.35pt"><span style="width:9.41pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of additional haemodynamic parameters including the assessment of pulmonary pressures; and</span></li></ol></li><li style="margin-left:16.15pt; text-indent:-16.15pt; line-height:normal"><span style="width:3.94pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130) or an item in Subgroup 3 applies (R)</span></li></ol></td><td style="width:15.16%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; text-align:right; line-height:normal"><span>210.75</span></p></td></tr><tr><td style="width:14.06%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="line-height:normal"><span>55134</span></p></td><td style="width:70.78%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>Repeat real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, for rare cardiac pathologies, if:</span></p><ol class="awlist19" style="margin:0pt; padding-left:0pt"><li style="margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.79pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the service involves all of the following, where possible:</span><ol class="awlist20" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:27.5pt; text-indent:-28.35pt"><span style="width:17.97pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and</span></li><li style="margin-top:3pt; margin-left:27.5pt; text-indent:-28.35pt"><span style="width:14.91pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of right ventricular structure and function with quantitative assessment; and</span></li><li style="margin-top:3pt; margin-left:27.5pt; text-indent:-28.35pt"><span style="width:11.86pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of left and right atrial structure including quantification of atrial sizes; and</span></li><li style="margin-top:3pt; margin-left:27.5pt; text-indent:-28.35pt"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of vascular connections of the heart including the great vessels and systemic venous structures; and</span></li><li style="margin-top:3pt; margin-left:27.5pt; text-indent:-28.35pt"><span style="width:15.52pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and</span></li><li style="margin-top:3pt; margin-left:27.35pt; text-indent:-28.35pt"><span style="width:12.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave doppler techniques with quantification of stenosis or regurgitation; and</span></li><li style="margin-top:3pt; margin-left:27.35pt; text-indent:-28.35pt"><span style="width:9.41pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>assessment of additional haemodynamic parameters including the assessment of pulmonary pressures; and</span></li></ol></li><li style="margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.17pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the service is requested by a specialist or consultant physician; and</span></li><li style="margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.79pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130) or an item in Subgroup 3 applies (R)</span></li></ol></td><td style="width:15.16%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="text-align:right; line-height:normal"><span>234.15</span></p></td></tr><tr><td style="width:14.06%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>55137</span></p></td><td style="width:70.78%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>Serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 4 acoustic windows, with recordings on digital media:</span></p><ol class="awlist21" style="margin:0pt; padding-left:0pt"><li style="margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.79pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>for the investigation of a fetus with suspected or confirmed of one or more of the following:</span></li></ol><ol class="awlist22" style="margin:0pt; padding-left:0pt"><li style="margin-left:51.55pt; text-indent:-35.45pt; line-height:normal"><span style="width:25.07pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>complex congenital heart disease; or</span></li><li style="margin-left:51.55pt; text-indent:-35.45pt; line-height:normal"><span style="width:22.01pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>functional heart disease; or</span></li><li style="margin-left:51.55pt; text-indent:-35.45pt; line-height:normal"><span style="width:18.96pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>fetal cardiac arrhythmia; or</span></li><li style="margin-left:51.55pt; text-indent:-35.45pt; line-height:normal"><span style="width:19.57pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>cardiac structural abnormality requiring confirmation; and</span></li></ol><ol class="awlist23" style="margin:0pt; padding-left:0pt"><li style="margin-left:17.85pt; text-indent:-17.85pt; line-height:normal"><span style="width:5.02pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the service involves the assessment all of the following, where possible:</span></li></ol><ol class="awlist24" style="margin:0pt; padding-left:0pt"><li style="margin-left:51.55pt; text-indent:-35.45pt; line-height:normal"><span style="width:25.07pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>ventricular structure and function; and</span></li><li style="margin-left:51.55pt; text-indent:-35.45pt; line-height:normal"><span style="width:22.01pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>atrial structure; and</span></li><li style="margin-left:51.55pt; text-indent:-35.45pt; line-height:normal"><span style="width:18.96pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>vascular connections of the heart including the great vessels and systemic venous structures; and</span></li><li style="margin-left:51.55pt; text-indent:-35.45pt; line-height:normal"><span style="width:19.57pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and</span></li><li style="margin-left:51.55pt; text-indent:-35.45pt; line-height:normal"><span style="width:22.62pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>all present valves including structural assessment and measurement of blood flow velocities across the valves using relevant doppler techniques with quantification; and</span></li></ol><ol class="awlist25" style="margin:0pt; padding-left:0pt"><li style="margin-left:17.85pt; text-indent:-17.85pt; line-height:normal"><span style="width:5.64pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the service is performed by a specialist or consultant physician practising in the speciality of cardiology with advanced training and expertise in fetal cardiac imaging; and</span></li><li style="margin-left:17.85pt; text-indent:-17.85pt; line-height:normal"><span style="width:5.02pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>not being a service associated with a service to which another item in this Subgroup (except items 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130) or an item in Subgroup 3 applies (R)</span></li></ol></td><td style="width:15.16%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; text-align:right; line-height:normal"><span>234.15</span></p></td></tr><tr><td style="width:14.06%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>55141</span></p></td><td style="width:70.78%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>Exercise stress echocardiography focused study if;</span></p><ol class="awlist26" style="margin:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.79pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the service involves all of the following:</span></li></ol><ol class="awlist27" style="margin:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:36pt; text-indent:-18pt; line-height:normal"><span style="width:7.62pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>two-dimensional recordings before exercise (baseline) from at least 2 acoustic windows; and</span></li><li style="margin-top:3pt; margin-left:36pt; text-indent:-18pt; line-height:normal"><span style="width:4.56pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>matching recordings at or immediately after peak exercise, which include at least parasternal short and long axis views, and apical 4-chamber and 2 chamber views; and</span></li><li style="margin-top:3pt; margin-left:36pt; text-indent:-18pt; line-height:normal"><span style="width:1.51pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>recordings on digital media with equipment permitting display of baseline and matching peak images on the same screen; and</span></li><li style="margin-top:3pt; margin-left:36pt; text-indent:-18pt; line-height:normal"><span style="width:2.12pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>resting electrocardiogram and continuous multi-channel electrocardiogram monitoring and recording during stress; and</span></li><li style="margin-top:3pt; margin-left:36pt; text-indent:-18pt; line-height:normal"><span style="width:5.17pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>blood pressure monitoring and the recording of other parameters (including heart rate); and</span></li></ol><ol class="awlist28" style="margin:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.17pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>cannot be claimed if a service associated with a service to which item 55143, 55145 or 55146 applies is provided in the previous 24 months; and</span></li><li style="margin-top:3pt; margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.79pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies; and</span></li><li style="margin-top:3pt; margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.17pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>not being a service associated with a service to which an item in Subgroup 3 applies</span></li></ol><p style="margin-top:3pt; line-height:normal"><span>For any particular patient, applicable not more than once in 24 months (R)</span></p></td><td style="width:15.16%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; text-align:right; line-height:normal"><span>417.45</span></p></td></tr><tr><td style="width:14.06%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>55143</span></p></td><td style="width:70.78%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>Repeat pharmacological or exercise stress echocardiography if:</span></p><ol class="awlist29" style="margin:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:17.85pt; text-indent:-17.85pt; line-height:normal"><span style="width:5.64pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the patient has had a service associated with a service to which item 55141, 55145 or 55146 applies provided in the previous 24 months; and</span></li><li style="margin-top:3pt; margin-left:17.85pt; text-indent:-17.85pt; line-height:normal"><span style="width:5.02pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the patient has symptoms of ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and</span></li><li style="margin-top:3pt; margin-left:17.85pt; text-indent:-17.85pt; line-height:normal"><span style="width:5.64pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the service is requested by a specialist or a consultant physician; and</span></li><li style="margin-top:3pt; margin-left:17.85pt; text-indent:-17.85pt; line-height:normal"><span style="width:5.02pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies; and</span></li><li style="margin-top:3pt; margin-left:17.85pt; text-indent:-17.85pt; line-height:normal"><span style="width:5.64pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>not being a service associated with a service to which an item in Subgroup 3 applies</span></li></ol><p style="margin-top:3pt; line-height:normal"><span>For any particular patient, applicable not more than once in 12 months (R)</span></p></td><td style="width:15.16%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; text-align:right; line-height:normal"><span>417.45</span></p></td></tr><tr><td style="width:14.06%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>55145</span></p></td><td style="width:70.78%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>Pharmacological stress echocardiography if:</span></p><ol class="awlist30" style="margin:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.79pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the service involves all of the following:</span></li></ol><ol class="awlist31" style="margin:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:36pt; text-indent:-18pt; line-height:normal"><span style="width:7.62pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>two-dimensional recordings before drug infusion (baseline) from at least 2 acoustic windows; and</span></li><li style="margin-top:3pt; margin-left:36pt; text-indent:-18pt; line-height:normal"><span style="width:4.56pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>matching recordings at least twice during drug infusion, including a recording at the peak drug dose, which include at least parasternal short and long axis views, and apical 4-chamber and 2 chamber views; and</span></li><li style="margin-top:3pt; margin-left:36pt; text-indent:-18pt; line-height:normal"><span style="width:1.51pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>recordings on digital media with equipment permitting display of baseline and matching peak images on the same screen; and</span></li><li style="margin-top:3pt; margin-left:36pt; text-indent:-18pt; line-height:normal"><span style="width:2.12pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>resting electrocardiogram and continuous multi-channel electrocardiogram monitoring and recording during stress; and</span></li><li style="margin-top:3pt; margin-left:36pt; text-indent:-18pt; line-height:normal"><span style="width:5.17pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>blood pressure monitoring and the recording of other parameters (including heart rate); and</span></li></ol><ol class="awlist32" style="margin:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.17pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>a service to which item 55141, 55146 or 55143 applies has not been provided in the previous 24 months; and</span></li><li style="margin-top:3pt; margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.79pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies; and</span></li><li style="margin-top:3pt; margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.17pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>not being a service associated with a service to which an item in Subgroup 3 applies</span></li></ol><p style="margin-top:3pt; line-height:normal"><span>For any particular patient, applicable not more than once in 24 months (R)</span></p></td><td style="width:15.16%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; text-align:right; line-height:normal"><span>483.85</span></p></td></tr><tr><td style="width:14.06%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:12pt"><span>55146</span></p></td><td style="width:70.78%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:normal"><span>Pharmacological stress echocardiography if:</span></p><ol class="awlist33" style="margin:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:18pt; text-indent:-17.85pt; line-height:normal"><span style="width:5.64pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the service involves all of the following:</span></li></ol><ol class="awlist34" style="margin:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:36pt; text-indent:-17.85pt; line-height:normal"><span style="width:7.47pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>two-dimensional recordings before drug infusion (baseline) from at least 2 acoustic windows; and</span></li><li style="margin-top:3pt; margin-left:36pt; text-indent:-18pt; line-height:normal"><span style="width:4.56pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>matching recordings at least twice during drug infusion, including a recording at the peak drug dose, which include at least parasternal short and long axis views, and apical 4-chamber and 2 chamber views; and</span></li><li style="margin-top:3pt; margin-left:35.7pt; text-indent:-17.85pt; line-height:normal"><span style="width:1.36pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>recordings on digital media with equipment permitting display of baseline and matching peak images on the same screen; and</span></li><li style="margin-top:3pt; margin-left:35.7pt; text-indent:-17.85pt; line-height:normal"><span style="width:1.97pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>resting electrocardiogram and continuous multi-channel electrocardiogram monitoring and recording during stress; and</span></li><li style="margin-top:3pt; margin-left:36pt; text-indent:-18pt; line-height:normal"><span style="width:5.17pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>blood pressure monitoring and the recording of other parameters (including heart rate); and</span></li></ol><ol class="awlist35" style="margin:0pt; padding-left:0pt"><li style="margin-top:3pt; margin-left:17.85pt; text-indent:-17.85pt; line-height:normal"><span style="width:5.02pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the patient has had a service performed under item 55141 in the previous 4 weeks and the test has failed due to an inadequate heart rate response; and</span></li><li style="margin-top:3pt; margin-left:17.85pt; text-indent:-17.85pt; line-height:normal"><span style="width:5.64pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>a service to which item 55143 or 55145 applies has not been provided in the previous 24 months; and</span></li><li style="margin-top:3pt; margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.17pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies; and</span></li><li style="margin-top:3pt; margin-left:18pt; text-indent:-18pt; line-height:normal"><span style="width:5.79pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>not being a service associated with a service to which an item in Subgroup 3 applies</span></li></ol><p style="margin-top:3pt; line-height:normal"><span>For any particular patient, applicable not more than once in 24 months (R)</span></p></td><td style="width:15.16%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; text-align:right; line-height:12pt"><span>483.85</span></p></td></tr></tbody></table>